Heart Disease News and Research

Latest Heart Disease News and Research

Warfarin may not be beneficial to some patients with atrial fibrillation: Researchers

Researchers at the University of Cincinnati and Massachusetts General Hospital have found that warfarin, a known anticoagulation (blood-thinning) drug, may not be as beneficial to some patients with atrial fibrillation as previously thought.

9 Dec 2010

The Joint Commission names AMC as Certified Primary Stroke Center

Adventist Medical Center, a nonprofit, 302-bed acute care hospital in southeast Portland, Ore., has been named a Certified Primary Stroke Center by The Joint Commission. This distinction means AMC offers fast and effective stroke care, and has a commitment to continuing education and improvement to issues connected with stroke.

9 Dec 2010

Expert discusses androgen deprivation therapy for prostate cancer

A common prostate cancer treatment, the ‘androgen deprivation therapy’ has often been prescribed for low-risk prostate cancer patients. This therapy for treating prostate cancer had previously been blamed for increased risk of cardiovascular disease and heart conditions.

9 Dec 2010

Acorda initiates enrollment in GGF2 Phase 1 clinical trial in patients with heart failure

Acorda Therapeutics, Inc. today announced that the first patient has been enrolled in the first clinical trial of Glial Growth Factor 2 (GGF2). Acorda is collaborating with the Vanderbilt University Heart and Vascular Institute to conduct this Phase 1 single-dose trial in patients with heart failure.

9 Dec 2010

LUMEDX implements CardioInventory software at Iowa Health Systems' affiliate hospitals

LUMEDX Corporation, a leading provider of vendor-neutral, integrated cardiovascular imaging and information systems (CVIS), announced the successful implementation of CardioInventory at nine Iowa Health Systems (IHS) affiliate hospitals. The final go-live at St. Luke's Medical Center in Cedar Rapids represents an important milestone in the ongoing installation of a centralized, enterprise-wide LUMEDX cardiovascular image- and data-management system for Iowa Health System.

9 Dec 2010

HeartWare announces $100 million convertible senior notes offering

HeartWare International, Inc. announced today its intention to offer, subject to market and other conditions, $100 million principal amount of convertible senior notes due 2017 (the "notes") pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission ("SEC") today. HeartWare also intends to grant the underwriters an option to purchase up to an additional $15 million principal amount of notes to cover over-allotments, if any.

9 Dec 2010

Cardiac Science adds two ECGs to Burdick line

Cardiac Science Corporation, a global leader in automated external defibrillator (AED) and diagnostic cardiac monitoring devices, today adds two electrocardiographs (ECGs) under its Burdick brand, known for its accuracy, reliability, and ease of use. The ECGs, available only in the U.S., deliver built-in, bi-directional communication so customers can connect to leading EMRs.

9 Dec 2010

Geisinger Medical Center performs first transcervical thymectomy

The Department of Thoracic Surgery at Geisinger Medical Center (GMC) recently performed its first transcervical thymectomy, joining other major academic medical centers nationwide that perform the minimally invasive surgical procedure.

9 Dec 2010

EFSA publishes positive opinion on disease risk reduction health claim for oat beta-glucan

A scientific panel of the European Food Safety Authority (EFSA) published its positive opinion on a disease risk reduction health claim dossier for oat beta-glucan on 8. December 2010, following an application from CreaNutrition AG submitted pursuant to Article 14 of the EC regulation on nutrition and health claims.

9 Dec 2010

Health care systems inadequate for managing acute GI hemorrhage outside of normal hours

Patients treated by Welsh hospitals for upper gastrointestinal (GI) bleeding were 41% more likely to die if they were admitted on a public holiday and 13% more likely if it was at the weekend, according to research in the January issue of Alimentary Pharmacology and Therapeutics.

9 Dec 2010

New software predicts key information about nasal insulin treatment regimens in type 1 diabetes

A La Jolla Institute team, led by leading type 1 diabetes researcher Matthias von Herrath, M.D., has demonstrated the effectiveness of a recently developed computer model in predicting key information about nasal insulin treatment regimens in type 1 (juvenile) diabetes. Development of the software, the Type 1 Diabetes PhysioLab- Platform, was funded through the peer-reviewed grant program of the American Diabetes Association.

9 Dec 2010

Sunovion reports results of Latuda third phase 3 worldwide clinical trial for schizophrenia

Sunovion Pharmaceuticals Inc. today announced the results of the PEARL 3 study, the third phase 3 worldwide clinical trial of Latuda® (lurasidone HCl) tablets, a once-daily atypical antipsychotic agent recently approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with schizophrenia. In this six-week, placebo-controlled trial, both fixed doses of LATUDA 80 and 160 mg once-daily, demonstrated statistically significant improvement in symptoms of schizophrenia versus placebo across both primary and secondary efficacy measures.

9 Dec 2010

Researchers to study effect of resveratrol on impaired IGT in older prediabetic patients

Researchers at Albert Einstein College of Medicine of Yeshiva University have been awarded $600,000 from the American Diabetes Association to study the effect of resveratrol, a chemical compound most notably found in red wine and grapes, on impaired glucose tolerance in older adults.

9 Dec 2010

St. Jude Medical announces advanced technologies for streamlined workflow in EP lab

St. Jude Medical, Inc., a global medical device company, today announced several new products that provide physicians and hospitals with the opportunity for improved efficiency and information connectivity in the electrophysiology (EP) lab. The EnSite Connect™ Remote Support feature, EnSite Courier™ Module, EnSite Velocity v2.0™ Software and recently launched EnSite Derexi™ Module are advanced technologies that allow a streamlined workflow within the EP lab.

9 Dec 2010

Downstream cancer care linked to complications during surgery

Patients who have complications after colorectal cancer surgery are less likely to get chemotherapy, even when it is clearly recommended for their diagnosis, a new study from the University of Michigan Comprehensive Cancer Center finds.

9 Dec 2010

Nottingham researchers develop new 'score' to detect heart disease in younger people

Experts at The University of Nottingham have developed a new 'score' to help GPs detect heart disease in younger people - before it damages their health.

9 Dec 2010

Bioheart group to advance BRIDGE TO RECOVERY clinical trial

Bioheart, Inc. announced today that at the American Heart Association Annual Meeting, it finalized the formation of a working group. The group's focus is to advance a BRIDGE TO RECOVERY clinical trial, combining a left ventricle assist device (LVAD) and Bioheart's MyoCell adult muscle stem cell composition and Bioheart's MyoCath needle tipped catheter delivery system.

9 Dec 2010

Poorly educated people more likely to be admitted in hospital with chronic heart failure

Results from a large European study suggest that poorly educated people are more likely to be admitted to hospital with chronic heart failure than the better educated, even after differences in lifestyle have been taken into account. The study is published online today (Thursday 9 December) in the European Heart Journal.

9 Dec 2010

Low-cost protein gets big results in people with elevated blood pressure

Beverages supplemented by whey-based protein can significantly reduce elevated blood pressure, reducing the risk of stroke and heart disease, a Washington State University study has found.

8 Dec 2010

New Hora de Hablar CARDIO program launched to help better manage heart health

An innovative new program, Hora de Hablar CARDIO – Creando la Atencion Real y Dialogo Inmediato en la Oficina, launched today to encourage patients and health care professionals to actively partner to help better manage heart health through more productive conversations during medical visits.

8 Dec 2010

Heart Disease News and Research

Latest Heart Disease News and Research

Warfarin may not be beneficial to some patients with atrial fibrillation: Researchers

The Joint Commission names AMC as Certified Primary Stroke Center

Expert discusses androgen deprivation therapy for prostate cancer

Acorda initiates enrollment in GGF2 Phase 1 clinical trial in patients with heart failure

LUMEDX implements CardioInventory software at Iowa Health Systems' affiliate hospitals

HeartWare announces $100 million convertible senior notes offering

Cardiac Science adds two ECGs to Burdick line

Geisinger Medical Center performs first transcervical thymectomy

EFSA publishes positive opinion on disease risk reduction health claim for oat beta-glucan

Health care systems inadequate for managing acute GI hemorrhage outside of normal hours

New software predicts key information about nasal insulin treatment regimens in type 1 diabetes

Sunovion reports results of Latuda third phase 3 worldwide clinical trial for schizophrenia

Researchers to study effect of resveratrol on impaired IGT in older prediabetic patients

St. Jude Medical announces advanced technologies for streamlined workflow in EP lab

Downstream cancer care linked to complications during surgery

Nottingham researchers develop new 'score' to detect heart disease in younger people

Bioheart group to advance BRIDGE TO RECOVERY clinical trial

Poorly educated people more likely to be admitted in hospital with chronic heart failure

Low-cost protein gets big results in people with elevated blood pressure

New Hora de Hablar CARDIO program launched to help better manage heart health

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Heart Disease News and Research

Latest Heart Disease News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in